Afinitor

Active Ingredient(s): Everolimus
FDA Approved: * March 30, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Cancer

Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants[8] and as a targeted therapy in the treatment of renal cell cancer and other tumours.[9] It is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).[10] It is marketed by Novartis under the trade names Zortress (US)... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Afinitor 5;NVR
Afinitor 5 mg Oral Tablet
NDC: 0078-0566
Labeler:
Novartis Pharmaceuticals Corporation
Afinitor UHE;NVR
Afinitor 10 mg Oral Tablet
NDC: 0078-0567
Labeler:
Novartis Pharmaceuticals Corporation
Afinitor 2.5 mg Oral Tablet
NDC: 0078-0594
Labeler:
Novartis Pharmaceuticals Corporation
Afinitor 7.5 mg Oral Tablet
NDC: 0078-0620
Labeler:
Novartis Pharmaceuticals Corporation
Afinitor 0.08 mg/ml Oral Suspension
NDC: 0078-0626
Labeler:
Novartis Pharmaceuticals Corporation
Afinitor 0.12 mg/ml Oral Suspension
NDC: 0078-0627
Labeler:
Novartis Pharmaceuticals Corporation
Afinitor 0.2 mg/ml Oral Suspension
NDC: 0078-0628
Labeler:
Novartis Pharmaceuticals Corporation

Related Brands

Drugs with the same active ingredients

Popular Topics

Afinitor reviews

Can anyone share their experience with taking afinitor, mainly the side effects, especially if you are taking it for neu...

1 REPLY
Renal cell carcinoma and Afinitor

My daughter has stage 4 renal cell carcinoma, the cancer has metastasized to her lungs, lymph nodes and vena cava vein. ...

1 REPLY